JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB127617

Recombinant human PI3K(p110alpha/p55gamma) protein (Active)

Be the first to review this product! Submit a review

|

(10 Publications)

Recombinant human PI3K(p110alpha/p55gamma) protein (Active) is a Human Full Length protein, expressed in Baculovirus infected Sf9 cells, with >70%, suitable for SDS-PAGE, WB, FuncS.

View Alternative Names

PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, Phosphoinositide 3-kinase alpha, Phosphoinositide-3-kinase catalytic alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit p110-alpha, p110alpha, PIK3CA, PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, Phosphoinositide 3-kinase alpha, Phosphoinositide-3-kinase catalytic alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit p110-alpha, p110alpha, PIK3CA

4 Images
Functional Studies - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
  • FuncS

Supplier Data

Functional Studies - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)

The specific activity of ab127617 was found to be 420 nmol/min/mg as per activity assay protocol.

Functional Studies - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
  • FuncS

Unknown

Functional Studies - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)

The specific activity of PI3K(p110alpha/p55gamma) (ab127617) was determined to be 357 nmol/min/mg as per activity assay protocol

SDS-PAGE - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)

SDS PAGE analysis of ab127617

SDS-PAGE - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant human PI3K(p110alpha/p55gamma) protein (Active) (AB127617)

Purity >70% by densitometry.

p110alpha ~111kDa

p55gamma ~61kDa

Key facts

Purity

>70% Densitometry

Expression system

Baculovirus infected Sf9 cells

Tags

His tag N-Terminus

Applications

WB, SDS-PAGE, FuncS

applications

Biologically active

Yes

Biological activity

420 nmol/min/mg.

Accession

P42336

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7 Preservative: 1.02% Imidazole Constituents: 25% Glycerol (glycerin, glycerine), 1.74% Sodium chloride, 0.82% Sodium phosphate, 0.00385% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00174% PMSF

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"HHHHHHLVPRGSPEFMPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREPKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALNMYNTVWSMDRDDADWREVMMPYSTELIFYIEMDPPALPPKPPKPMTSAVPNGMKPSSVSLQDAEWYWGDISREEVNDKLRDMPDGTFLVRDASTKMQGDYTLTLRKGGNNKLIKIYHRDGKYGFSDPLTFNSVVELINHYHHESLAQYNPKLDVKLMYPVSRYQQDQLVKEDNIDAVGKKLQEYHSQYQEKSKEYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCHTQEQHSKEYIERFRREGNEKEIERIMMNYDKLKSRLGEIHDSKMRLEQDLKNQALDNREIDKKMNSIKPDLIQLRKIRDQHLVWLNHKGVRQKRLNVWLGIKNEDADENYFINEEDENLPHYDEKTWFVEDINRVQAEDLLYGKPDGAFLIRESSKKGCYACSVVADGEVKHCVIYSTARGYGFAEPYNLYSSLKELVLHYQQTSLVQHNDSLNVRLAYPVHAQMPSLCR","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":"Baculovirus infected Sf9 cells","accessionNumber":"Q92569","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PI3K p110alpha/p55gamma often referred to as PI3Kα is a member of the phosphoinositide 3-kinases (PI3Ks) family. It plays a significant role in intracellular signal transduction. PI3Kα is a heterodimer composed of a p110 catalytic subunit and a p55 regulatory subunit. The molecular mass of the p110alpha subunit is approximately 124 kDa while the p55gamma regulatory subunit has a mass of around 55 kDa. PI3Kα expresses mainly in tissues with high cellular proliferation rates such as liver heart and muscle indicating its involvement in key biological processes.
Biological function summary

PI3Kα regulates cellular functions by participating in lipid phosphorylation at the 3-position of the inositol ring producing phosphatidylinositol (345)-trisphosphate (PIP3). This is an important event in recruiting signaling proteins with PH domains to the membrane leading to the activation of kinases like AKT. PI3Kα usually forms part of a complex with other proteins in order to facilitate its functions. This complex arrangement aids in mediating cell growth proliferation survival and metabolic responses making it a central player in cellular physiology.

Pathways

PI3Kα integrates into the PI3K/AKT/mTOR pathway a critical signaling cascade that controls myriad cellular processes. Within this pathway PI3Kα activates AKT which in turn interacts with downstream effectors like mTOR to regulate cellular metabolism and growth. PI3Kα also connects with proteins like PTEN and PDK1 to maintain a balance between cell survival and apoptosis. Besides this pathway influences glucose homeostasis and can affect various cellular states through intricate signaling networks.

PI3Kα links strongly with cancer and insulin resistance conditions like Type 2 diabetes. Mutations and overexpression of PI3Kα have associations with several cancer types including breast and colorectal cancers by driving unchecked cellular proliferation and survival. In insulin resistance dysfunctional PI3Kα impair signaling through the insulin pathway reducing the responsiveness of cells to insulin and affecting glucose uptake. The interaction of PI3Kα with proteins such as PTEN and AKT plays an important role in these pathological conditions underlining its importance as a target in therapeutic interventions.

Specifications

Form

Liquid

Additional notes

Affinity purified.

General info

Function

Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed : 15135396, PubMed : 23936502, PubMed : 28676499). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed : 15135396, PubMed : 28676499). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. In addition to its lipid kinase activity, it displays a serine-protein kinase activity that results in the autophosphorylation of the p85alpha regulatory subunit as well as phosphorylation of other proteins such as 4EBP1, H-Ras, the IL-3 beta c receptor and possibly others (PubMed : 23936502, PubMed : 28676499). Plays a role in the positive regulation of phagocytosis and pinocytosis (By similarity).

Sequence similarities

Belongs to the PI3/PI4-kinase family.

Product protocols

Target data

Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed : 15135396, PubMed : 23936502, PubMed : 28676499). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed : 15135396, PubMed : 28676499). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. In addition to its lipid kinase activity, it displays a serine-protein kinase activity that results in the autophosphorylation of the p85alpha regulatory subunit as well as phosphorylation of other proteins such as 4EBP1, H-Ras, the IL-3 beta c receptor and possibly others (PubMed : 23936502, PubMed : 28676499). Plays a role in the positive regulation of phagocytosis and pinocytosis (By similarity).
See full target information PIK3CA

Additional targets

PIK3CA

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Molecular vision 27:725-733 PubMed35035207

2021

Ligustrazine protects against chronic hypertensive glaucoma in rats by inhibiting autophagy via the PI3K-Akt/mTOR pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hong-Yan Du,Rong Wang,Jian-Liang Li,Huang Luo,Xiao-Yan Xie,Ran Yan,Yue-Ling Jian,Jin-Ying Cai

Experimental and therapeutic medicine 21:373 PubMed33732346

2021

MicroRNA-145-5p aggravates cell apoptosis and oxidative stress in tongue squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Zengxi Xin,Zhou Tong,Jingyu Tan,Changfu Liu

Bioengineered 12:507-515 PubMed33522374

2021

Ligustrazine induces viability, suppresses apoptosis and autophagy of retinal ganglion cells with ischemia/reperfusion injury through the PI3K/Akt/mTOR signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hong-Yan Du,Rong Wang,Jian-Liang Li,Huang Luo,Xiao-Yan Xie,Ran Yan,Yue-Ling Jian,Jin-Ying Cai

Molecular medicine reports 21:1709-1716 PubMed32319634

2020

Long non‑coding RNA H19 protects H9c2 cells against hypoxia‑induced injury by activating the PI3K/AKT and ERK/p38 pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Linhui Yuan,Leitao Yu,Jing Zhang,Zhidong Zhou,Chang Li,Bin Zhou,Xiaolan Hu,Guohai Xu,Yanhua Tang

Journal of experimental & clinical cancer research 38:410 PubMed31533855

2019

UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Jian-Xian Lin,Xin-Sheng Xie,Xiong-Feng Weng,Sheng-Liang Qiu,Changhwan Yoon,Ning-Zi Lian,Jian-Wei Xie,Jia-Bin Wang,Jun Lu,Qi-Yue Chen,Long-Long Cao,Mi Lin,Ru-Hong Tu,Ying-Hong Yang,Chang-Ming Huang,Chao-Hui Zheng,Ping Li

Experimental and therapeutic medicine 18:3543-3551 PubMed31602231

2019

MicroRNA-21-5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Changfu Liu,Zhou Tong,Jingyu Tan,Zengxi Xin,Zhiying Wang,Luming Tian

Cell proliferation 52:e12651 PubMed31297902

2019

Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Tiancheng Li,Yao Qin,Zhen Zhen,Hong Shen,Tiechuan Cong,Erik Schiferle,Shuifang Xiao

Neuroscience bulletin 35:471-485 PubMed30684126

2019

Up-Regulation of Trem2 Inhibits Hippocampal Neuronal Apoptosis and Alleviates Oxidative Stress in Epilepsy via the PI3K/Akt Pathway in Mice.

Applications

Unspecified application

Species

Unspecified reactive species

Ai-Hua Liu,Min Chu,Yu-Ping Wang

Pathology, research and practice 215:115-120 PubMed30396754

2018

MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Dajiang Wu,Hao Zhang,Fang Ji,Wenbin Ding

Molecular medicine reports 13:1097-104 PubMed26647768

2015

Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Ji-Cheng Tantai,Yao Zhang,Heng Zhao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com